Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Banked Sky-High Profits After Hiking Prices

Earnings reports for the fourth quarter of 2019 provide the latest evidence that Big Pharma continues to bank sky-high profits while price-gouging American patients. Today, brand name drug giant AstraZeneca announced rising profits completing a trend that holds across the board for the world’s largest brand name drug companies.

The brand name giant continues to hike prices on American patients, despite the escalating crisis of affordability and heightened attention around out-of-control prescription drug prices.
AstraZeneca has a long history of hiking prices on Americans struggling to afford their medications:

This quarter all 12 of the world’s largest brand name drug companies – including Johnson & Johnson, Eli Lilly, Roche, Novartis, Pfizer, Amgen, Merck, GlaxoSmithKline, Bristol-Myers Squibb and Abbvie – raked in high profits after continuing to increase prices on struggling Americans.

Congress must act to hold Big Pharma accountable and deliver much needed relief for American patients by passing bipartisan, market-based solutions.

Learn more on market-based measures to hold Big Pharma accountable and lower prescription drug prices with significant bipartisan support in Congress HERE.


Sign-up for updates

  • This field is for validation purposes and should be left unchanged.